Cancer Research Cell Death Mechanisms and Cancer Therapy EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCawley, L. J.
Right arrow Articles by Matrisian, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCawley, L. J.
Right arrow Articles by Matrisian, L. M.
[Cancer Research 64, 6965-6972, October 1, 2004]
© 2004 American Association for Cancer Research

Regular Articles

A Protective Role for Matrix Metalloproteinase-3 in Squamous Cell Carcinoma

Lisa J. McCawley1, Howard C. Crawford1, Lloyd E. King, Jr.2, John Mudgett3 and Lynn M. Matrisian1

1 Department of Cancer Biology and 2 Department of Medicine, Division of Dermatology, Vanderbilt University, Nashville, Tennessee; and 3 Merck Research Laboratories, Rahway, New Jersey

Elevated expression of matrix metalloproteinase-3 (MMP-3/stromelysin-1) is associated with a variety of tumor types, although its in vivo functional role remains unclear. In human and murine squamous cell carcinoma (SCC), MMP-3 is expressed in the stromal compartment at all of the stages of tumor progression and is expressed by the malignant epithelial cells in late-stage, highly invasive tumors. To elucidate whether MMP-3 plays a causal role during SCC, wild-type and MMP-3 null mice were subjected to chemical carcinogenesis procedures by topical application of either the complete carcinogen 1-methyl-3-nitro-1-nitroso-guanidine or two-stage initiation and promotion with 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate. Contrasting with our expectations, tumors originating on MMP-3 null mice had enhanced initial tumor growth rates as compared with control animals, although there was no difference in tumor onset or incidence. This elevated rate in growth was coupled with an elevated proliferative index and a reduced vasculature density but with no significant effect on apoptosis. Tumors from MMP-3 null mice had a prevalence of undifferentiated spindle tumors as compared with controls, which was concomitant with a higher percentage of MMP-3 null mice evidencing surface lung metastases. Tumor progression in MMP-3 null mice was inversely associated with leukocyte infiltration, in which an overall reduction in tumor-associated macrophages and neutrophils was evident. We propose that MMP-3 is expressed as a protective response and plays an important role in host defense during SCC tumorigenesis.




This article has been cited by other articles:


Home page
 JCOHome page
R. Roy, J. Yang, and M. A. Moses
Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer
J. Clin. Oncol., November 1, 2009; 27(31): 5287 - 5297.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. R. Dean, J. R. Newman, E. E. Helman, W. Zhang, S. Safavy, D.M. Weeks, M. Cunningham, L. A. Snyder, Y. Tang, L. Yan, et al.
Anti-EMMPRIN Monoclonal Antibody as a Novel Agent for Therapy of Head and Neck Cancer
Clin. Cancer Res., June 15, 2009; 15(12): 4058 - 4065.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. J. McCawley, J. Wright, B. J. LaFleur, H. C. Crawford, and L. M. Matrisian
Keratinocyte Expression of MMP3 Enhances Differentiation and Prevents Tumor Establishment
Am. J. Pathol., November 1, 2008; 173(5): 1528 - 1539.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Almholt, A. Juncker-Jensen, O. D. Laerum, K. Dano, M. Johnsen, L. R. Lund, and J. Romer
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model
Mol. Cancer Ther., September 1, 2008; 7(9): 2758 - 2767.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Gutierrez-Fernandez, A. Fueyo, A. R. Folgueras, C. Garabaya, C. J. Pennington, S. Pilgrim, D. R. Edwards, D. L. Holliday, J. L. Jones, P. N. Span, et al.
Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion
Cancer Res., April 15, 2008; 68(8): 2755 - 2763.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
K. J. Greenlee, Z. Werb, and F. Kheradmand
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Physiol Rev, January 1, 2007; 87(1): 69 - 98.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
K. Hotary, X.-Y. Li, E. Allen, S. L. Stevens, and S. J. Weiss
A cancer cell metalloprotease triad regulates the basement membrane transmigration program
Genes & Dev., October 1, 2006; 20(19): 2673 - 2686.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. B. Acuff, M. Sinnamon, B. Fingleton, B. Boone, S. E. Levy, X. Chen, A. Pozzi, D. P. Carbone, D. R. Schwartz, K. Moin, et al.
Analysis of Host- and Tumor-Derived Proteinases Using a Custom Dual Species Microarray Reveals a Protective Role for Stromal Matrix Metalloproteinase-12 in Non-Small Cell Lung Cancer
Cancer Res., August 15, 2006; 66(16): 7968 - 7975.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. R. Merchan, J. Tang, G. Hu, Y. Lin, W. Mutter, C. Tong, S. A. Karumanchi, S. J. Russell, and V. P. Sukhatme
Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
J Natl Cancer Inst, June 7, 2006; 98(11): 756 - 764.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Jost, A. R. Folgueras, F. Frerart, A. M. Pendas, S. Blacher, X. Houard, S. Berndt, C. Munaut, D. Cataldo, J. Alvarez, et al.
Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice.
Cancer Res., May 15, 2006; 66(10): 5234 - 5241.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. B. Acuff, K. J. Carter, B. Fingleton, D. L. Gorden, and L. M. Matrisian
Matrix Metalloproteinase-9 from Bone Marrow-Derived Cells Contributes to Survival but not Growth of Tumor Cells in the Lung Microenvironment
Cancer Res., January 1, 2006; 66(1): 259 - 266.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. S. Rao, C. Gondi, C. Chetty, S. Chittivelu, P. A. Joseph, and S. S. Lakka
Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells
Mol. Cancer Ther., September 1, 2005; 4(9): 1399 - 1408.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Kong, M. T. Longaker, and H. P. Lorenz
Cyclophilin C-associated Protein Is a Mediator for Fibronectin Fragment-induced Matrix Metalloproteinase-13 Expression
J. Biol. Chem., December 31, 2004; 279(53): 55334 - 55340.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.